Chris Coburn

Chris Coburn is the Chief Innovation Officer at Mass General Brigham. Chris leads a team of more than 125 people tasked with the worldwide commercial application of the unique capabilities and discoveries of all Mass General Brigham 80,000 employees. His unit’s business development responsibilities include investing, company creation, innovation management, industry collaborations, and licensing.

Under Chris’ leadership, commercialization revenue exceeds $130 million annually and more than 225 companies have been spun-off from Mass General Brigham in the last decade. Large-scale industry collaborations have been established in areas such as artificial intelligence and drug development. Provider strategy and operational consulting has been delivered to clients in nearly 40 countries. His team also manages a nearly $200 million venture fund.

Prior to joining Mass General Brigham, Chris was the founding director of Cleveland Clinic Innovations and served for 13 years as its executive leader. During his tenure, Cleveland Clinic spun off 57 companies that raised more than $700 million in equity financing. There were none before Chris’ arrival. His team also managed an innovation alliance network in which Cleveland Clinic directly supported technology commercialization for health care systems throughout the United States.

Chris has been a member of numerous corporate and community boards including Explorys (acquired by IBM), Autonomic Technologies, and the U.S. Enrichment Corporation (NYSE:USU).